Literature DB >> 9334934

Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification.

J W Zhang1, P E Gottschall.   

Abstract

Several methods have been developed for the measurement of gelatinase activity from various tissues using detergent extraction. Gelatin-affinity chromatography has been employed for the large-scale purification of gelatinases from conditioned medium obtained from cultured cells. The objective of this paper was to develop a rapid method whereby gelatinase activity could be extracted from regional brain tissues without tedious, intervening purification steps. After Triton X-100 extraction and gelatin-Sepharose 4B purification of rat brain tissue extracts, two major activities were observed on gelatin zymograms. These were identified as gelatinase A and B using co-migration with astrocyte-derived enzymes and inhibition of activity by tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). The non-ionic detergents, Triton X-100 and 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate (CHAPS) were equally effective in extracting activities from brain tissue. Little difference in recovery was observed among 0.1, 1 and 10% concentrations of Triton X-100. The method developed here was capable of recovering gelatinase activities from rat brain tissue over a 4-10-fold range using gelatin zymography for the measurement of activity. It is possible that this method may be modified for the measurement of gelatinases in tissues such as biopsy samples of gliomas or astrocytomas or other cancers where gelatinases are thought to play a role in tumor invasion and/or metastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334934     DOI: 10.1016/s0165-0270(97)00065-4

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  27 in total

1.  Ammonia increases paracellular permeability of rat brain endothelial cells by a mechanism encompassing oxidative/nitrosative stress and activation of matrix metalloproteinases.

Authors:  Marta Skowrońska; Magdalena Zielińska; Luiza Wójcik-Stanaszek; Joanna Ruszkiewicz; Dejan Milatovic; Michael Aschner; Jan Albrecht
Journal:  J Neurochem       Date:  2012-02-15       Impact factor: 5.372

2.  Matrix metalloproteinase-9 and cell division in neuroblastoma cells and bone marrow macrophages.

Authors:  M Gloria Sans-Fons; Sonia Sole; Coral Sanfeliu; Anna M Planas
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory.

Authors:  Vanja Nagy; Ozlem Bozdagi; George W Huntley
Journal:  Learn Mem       Date:  2007-09-25       Impact factor: 2.460

4.  Decrease of MMP-9 activity improves soleus muscle regeneration.

Authors:  Malgorzata Zimowska; Krzysztof H Olszynski; Marta Swierczynska; Wladyslawa Streminska; Maria A Ciemerych
Journal:  Tissue Eng Part A       Date:  2012-04-20       Impact factor: 3.845

5.  Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.

Authors:  Thomas M Reeves; Patricia A Trimmer; Beverly S Colley; Linda L Phillips
Journal:  Exp Neurol       Date:  2016-06-11       Impact factor: 5.330

6.  Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier.

Authors:  Weiming Tian; Andrew Sawyer; Feriha B Kocaoglu; Themis R Kyriakides
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

7.  A Combined Treatment with Taurine and Intra-arterial Thrombolysis in an Embolic Model of Stroke in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window.

Authors:  Weihua Guan; Yumei Zhao; Chao Xu
Journal:  Transl Stroke Res       Date:  2010-11-16       Impact factor: 6.829

8.  Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.

Authors:  Stefan Lorenzl; Noel Calingasan; Lichuan Yang; David S Albers; Shuei Shugama; Jason Gregorio; H W Krell; Jason Chirichigno; Tong Joh; M Flint Beal
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

9.  Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.

Authors:  Vanja Nagy; Ozlem Bozdagi; Anna Matynia; Marcin Balcerzyk; Pawel Okulski; Joanna Dzwonek; Rui M Costa; Alcino J Silva; Leszek Kaczmarek; George W Huntley
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

10.  Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.

Authors:  Harpreet Sidhu; Lorraine E Dansie; Peter W Hickmott; Douglas W Ethell; Iryna M Ethell
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.